Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02760407
Brief Title: Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (CREDO 2)

First Submitted : April 29, 2016
First Submitted that Met QC Criteria : May 2, 2016
First Posted : May 3, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 30, 2018
Last Update Posted : December 3, 2018